KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Intangibles (2016 - 2026)

Bio-Rad Laboratories has reported Intangibles over the past 18 years, most recently at $166.8 million for Q1 2026.

  • Quarterly Intangibles fell 43.67% to $166.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $166.8 million through Mar 2026, down 43.67% year-over-year, with the annual reading at $174.3 million for FY2025, 40.63% down from the prior year.
  • Intangibles was $166.8 million for Q1 2026 at Bio-Rad Laboratories, down from $174.3 million in the prior quarter.
  • Over five years, Intangibles peaked at $396.9 million in Q2 2025 and troughed at $166.8 million in Q1 2026.
  • The 5-year median for Intangibles is $313.6 million (2024), against an average of $298.8 million.
  • Year-over-year, Intangibles surged 83.58% in 2022 and then crashed 43.67% in 2026.
  • A 5-year view of Intangibles shows it stood at $332.1 million in 2022, then decreased by 3.51% to $320.5 million in 2023, then dropped by 8.39% to $293.6 million in 2024, then tumbled by 40.63% to $174.3 million in 2025, then fell by 4.3% to $166.8 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Intangibles are $166.8 million (Q1 2026), $174.3 million (Q4 2025), and $388.4 million (Q3 2025).